The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,105.00
Bid: 3,910.00
Ask: 4,130.00
Change: 0.00 (0.00%)
Spread: 220.00 (5.627%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,105.00
ULVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Buy-Back Programme completes

3 Dec 2021 15:37

RNS Number : 5726U
Unilever PLC
03 December 2021
 

Unilever completes share buyback programme

3 December 2021

 

London - Unilever PLC announces the successful completion of the second tranche of its share buyback programme initially announced on 29 April 2021 (the 'Second Tranche'). Under the Second Tranche, which began on 23 August 2021, 32,508,415 Unilever PLC shares were purchased with a total value equivalent of approximately €1,499,999,934.

 

Under the first tranche of this buyback programme, which began on 6 May 2021 and completed on 13 August 2021, 30,467,730 Unilever PLC shares were purchased.

 

All of the shares purchased in the buyback programme have been placed in treasury. As a result, Unilever PLC holds a total of 62,976,145 shares in treasury and has a total of 2,566,267,627 non-treasury shares in issue. Of the non-treasury shares in issue, a total of 5,301,252 shares (including shares represented by Unilever PLC ADSs) are held by or on behalf of companies in the Unilever group (the 'Unilever Group Shares'). The voting rights attaching to the Unilever Group Shares are not exercisable.

 

With the completion of the Second Tranche, Unilever has delivered on its intention, as announced on 29 April 2021, to buy back shares with an aggregate market value equivalent of up to €3 billion.

 

Please see the total voting rights announcement dated 1 December 2021 for Unilever PLC's latest total voting rights figure published under the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.

 

 

Unilever PLC

Unilever House100 Victoria EmbankmentLondon EC4Y 0DYUnited Kingdom

Press-Office.London@Unilever.com

 

 

CAUTIONARY STATEMENT

 

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance.

 

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; the effect of climate change on Unilever's business; Unilever's ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. A number of these risks have increased as a result of the current Covid-19 pandemic. These forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

 

Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2020 and the Unilever Annual Report and Accounts 2020 available on our corporate website. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBUBDDSXGDGBX
Date   Source Headline
27th Sep 20235:55 pmRNSTransaction in Own Shares
26th Sep 20235:53 pmRNSTransaction in Own Shares
25th Sep 20235:52 pmRNSTransaction in Own Shares
22nd Sep 20235:45 pmRNSTransaction in Own Shares
21st Sep 20235:38 pmRNSTransaction in Own Shares
20th Sep 20236:14 pmRNSTransaction in Own Shares
19th Sep 20236:00 pmRNSTransaction in Own Shares
18th Sep 20236:16 pmRNSTransaction in Own Shares
15th Sep 20236:04 pmRNSTransaction in Own Shares
14th Sep 20235:50 pmRNSTransaction in Own Shares
13th Sep 20235:27 pmRNSTransaction in Own Shares
12th Sep 20235:46 pmRNSTransaction in Own Shares
12th Sep 20239:37 amRNSDirector/PDMR Shareholding
11th Sep 20235:45 pmRNSTransaction in Own Shares
11th Sep 20237:00 amRNSTransaction in Own Shares
8th Sep 202311:38 amRNSDirector/PDMR Shareholding
8th Sep 20237:52 amRNSShare Buy-Back Programme
5th Sep 202311:21 amRNSDirector/PDMR Shareholding
1st Sep 20232:47 pmRNSDirector/PDMR Shareholding
1st Sep 20232:45 pmRNSTotal Voting Rights
10th Aug 20234:12 pmRNSDirector/PDMR Shareholding
2nd Aug 20232:00 pmRNSCancellation of Treasury Shares
1st Aug 202311:27 amRNSTotal Voting Rights
1st Aug 202310:15 amRNSDirector/PDMR Shareholding - Replacement
1st Aug 202310:09 amRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSUnilever PLC Announces Directorate Change
25th Jul 20237:00 amRNSHalf-year Report
12th Jul 20233:02 pmRNSDirector/PDMR Shareholding
3rd Jul 202312:33 pmRNSTotal Voting Rights
30th Jun 202310:10 amRNSBlock listing Six Monthly Return
20th Jun 20234:26 pmRNSDirector/PDMR Shareholding
16th Jun 20235:54 pmRNSDirector/PDMR Shareholding
9th Jun 202311:51 amRNSDirector/PDMR Shareholding
6th Jun 202311:46 amRNSDirector/PDMR Shareholding
5th Jun 20235:31 pmRNSShare Buyback Programme Update
2nd Jun 20234:57 pmRNSTransaction in Own Shares
1st Jun 20235:07 pmRNSTransaction in Own Shares
1st Jun 20234:22 pmRNSTotal Voting Rights
31st May 20234:58 pmRNSTransaction in Own Shares
30th May 20234:57 pmRNSTransaction in Own Shares
30th May 20237:00 amRNSDirectorate Change
26th May 20234:54 pmRNSTransaction in Own Shares
25th May 20234:48 pmRNSTransaction in Own Shares
25th May 20232:48 pmRNSPublication of Financial Statements for UFN
25th May 202311:23 amRNSDirector/PDMR Shareholding
24th May 20234:54 pmRNSTransaction in Own Shares
23rd May 20234:43 pmRNSTransaction in Own Shares
23rd May 20234:20 pmRNSDirector/PDMR Shareholding
22nd May 20234:48 pmRNSTransaction in Own Shares
19th May 20234:53 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.